Yarawsky Alexander E, Ciatto Carlo, Slade Peter, Figueroa Natalya I, Burgner John W, DeLion Michael T, Paul Lake N
BioAnalysis, LLC, 3401 I Street Suite 206, Philadelphia, PA 19134, USA.
Decibel Therapeutics, Inc., 1325 Boylston Street Suite 500, Boston, MA 02215, USA.
J Pharm Sci. 2025 Feb;114(2):900-910. doi: 10.1016/j.xphs.2024.10.049. Epub 2024 Oct 28.
Sedimentation velocity analytical ultracentrifugation (SV-AUC) has become the "gold standard" for characterization of the empty, partial, and full capsids of gene therapy products (e.g., AAV and Adenovirus vectors). Other techniques, such as SEC-MALS, TEM, and mass photometry, are commonly used for capsid quantitation, however, the resolving power of these techniques is lacking. In this body of work, SV-AUC was implemented in the characterization of a dual-vector AAV system where the difference in packaged genomes was ∼400 nucleotides. The instrument parameters and SV-AUC analysis were optimized to accurately quantitate both AAV vectors with less than 8% error and with highly correlated linearity (R > 0.99) as compared to ddPCR. The results of this work highlight the resolution and accuracy of dual-vector capsid quantitation by SV-AUC and demonstrate the use of the powerful Bayesian analysis implemented in the SEDFIT analysis software.
沉降速度分析超离心法(SV-AUC)已成为表征基因治疗产品(如腺相关病毒和腺病毒载体)的空衣壳、部分衣壳和完整衣壳的“金标准”。其他技术,如尺寸排阻色谱-多角度激光光散射法(SEC-MALS)、透射电子显微镜(TEM)和质量光度法,通常用于衣壳定量,然而,这些技术的分辨能力不足。在这项工作中,SV-AUC被用于表征一种双载体腺相关病毒系统,其中包装的基因组差异约为400个核苷酸。与数字滴液聚合酶链反应(ddPCR)相比,对仪器参数和SV-AUC分析进行了优化,以准确地定量两种腺相关病毒载体,误差小于8%,且具有高度相关的线性关系(R>0.99)。这项工作的结果突出了通过SV-AUC进行双载体衣壳定量的分辨率和准确性,并展示了在SEDFIT分析软件中实施的强大贝叶斯分析的应用。